Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window

 The financial results of the Company for the quarter March 31, 2020 will be declared in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the above captioned matter, we would like to inform you that pursuant to the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for prohibition of insider trading ('Code') the trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter ended March 31, 2020 for all the Designated person of the Company from Wednesday, April 01, 2020 and shall open 48 hours after announcement of the financial Results, for all its designated persons.
30-03-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Newspaper Advertisement Pursuant To Regulation 47 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015.

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we are enclosing herewith the copy of Newspaper advertisement of the Standalone unaudited Financial Results for the quarter ended 31st December, 2019 published in Business Standard (English Language) and Mumbai Lakshadeep (Marathi Language) on February 05, 2020 for your reference and record. Kindly take the note of the same.
11-02-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Contact Details Of KMP For Reporting Of Material Events

 Pursuant to Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of the CEO who is authorized to determine the materiality of an event are as under: Name Designation Contact Details Mr. Ravindra Desai CEO Aspira Pathlab & Diagnostics Limited R D Shah Building, Opp. Ghatkopar Railway Station, Ghatkopar West, Mumbai - 400 086 Contact No. 71975756 Further, after determining of any Material information/ Event by CEO, the Company Secretary shall disseminate the same to the Stock Exchange (s), whose contact details are given in attached file.
04-02-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Un-Audited Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31, 2020

 This is to inform you that the Board of Directors of the Company, at their meeting held today at 3.15 p.m. has approved the un-audited financial results of the Company for the third quarter and nine months ended December 31, 2019. The above financial Results along with the Limited Review Report on the Financial Results are enclosed herewith. The meeting of the Board of Directors was concluded at 5.30 p.m. Kindly take the same on your records.
04-02-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Un-Audited Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31, 2020

 This is to inform you that the Board of Directors of the Company, at their meeting held today at 3.15 p.m. has approved the un-audited financial results of the Company for the third quarter and nine months ended December 31, 2019. The above financial Results along with the Limited Review Report on the Financial Results are enclosed herewith. The meeting of the Board of Directors was concluded at 5.30 p.m. Kindly take the same on your records.
04-02-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome Of Meeting Of The Board Of Directors Of Aspira Pathlab & Diagnostics Limited, Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today has approved the unaudited Financial Results for third quarter and nine months ended December 31, 2019. The above financial Results along with the Limited Review Report on the Financial Results are enclosed herewith. The meeting of the Board of Directors was concluded at 5.30 p.m.
04-02-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome Of Meeting Of The Board Of Directors Of Aspira Pathlab & Diagnostics Limited, Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today has approved the unaudited Financial Results for third quarter and nine months ended December 31, 2019. The above financial Results along with the Limited Review Report on the Financial Results are enclosed herewith. The meeting of the Board of Directors was concluded at 5.15 p.m.
04-02-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Outcome Of Meeting Of The Board Of Directors Of Aspira Pathlab & Diagnostics Limited, Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').

 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today has approved the unaudited Financial Results for third quarter and nine months ended December 31, 2019. The above financial Results along with the Limited Review Report on the Financial Results are enclosed herewith. The meeting of the Board of Directors was concluded at 5.15 p.m.
04-02-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliance Under Regulation 47 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed Public Notice published in the Newspapers viz.- Business Standard (in English) and Mumbai Lakshdeep (in Marathi), informing about the Board Meeting scheduled to be held on 4th February, 2020 to, inter alia, consider and approve the Unaudited Financial Results of the Company for the Third Quarter and Nine months ended 31st December, 2019.
29-01-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2019.

 Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2020 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2019.
27-01-2020
Next Page
Close

Let's Open Free Demat Account